{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:28:54Z","timestamp":1777537734818,"version":"3.51.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T00:00:00Z","timestamp":1482796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00213-016-4514-4","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T14:38:11Z","timestamp":1482849491000},"page":"781-792","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["The contribution of \u03b14\u03b22 and non-\u03b14\u03b22 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice"],"prefix":"10.1007","volume":"234","author":[{"given":"Fernando B.","family":"de Moura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance R.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,27]]},"reference":[{"key":"4514_CR1","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1124\/mol.105.021782","volume":"69","author":"GR Abdrakhmanova","year":"2006","unstructured":"Abdrakhmanova GR, Damaj MI, Carroll FI, Martin BR (2006) 2-Fluoro-3-(4-nitro-phenyl)deschloroepibatidine is a novel potent competitive antagonist of human neuronal \u03b14\u03b22 nAChRs. Mol Pharmacol 69:1945\u20131952","journal-title":"Mol Pharmacol"},{"key":"4514_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(96)00010-6","volume":"301","author":"JD Brioni","year":"1996","unstructured":"Brioni JD, Kim DJ, O\u2019Neill AB (1996) Nicotine cue: lack of effect of the \u03b17 niconic receptor antagonist methyllycaconitine. Eur J Pharmacol 301:1\u20135","journal-title":"Eur J Pharmacol"},{"key":"4514_CR3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s002130050188","volume":"129","author":"CJ Chandler","year":"1997","unstructured":"Chandler CJ, Stolerman IP (1997) Discriminative stimulus properties of the nicotinic agonist cytisine. Psychopharmacology 129:257\u2013264","journal-title":"Psychopharmacology"},{"key":"4514_CR4","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/978-3-642-73223-2_12","volume-title":"Transduction mechanisms of drug stimuli","author":"FC Colpaert","year":"1988","unstructured":"Colpaert FC (1988) Intrinsic activity and discriminative effects of drugs. In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli. Springer Berlin Heidelberg, Berlin, pp 154\u2013160"},{"key":"4514_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0091-3057(99)00047-7","volume":"64","author":"FC Colpaert","year":"1999","unstructured":"Colpaert FC (1999) Drug discrimination in neurobiology. Pharmcol. Biochem Behav 64:337\u2013345","journal-title":"Biochem Behav"},{"key":"4514_CR6","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-3565(25)21381-7","volume":"230","author":"FC Colpaert","year":"1984","unstructured":"Colpaert FC, Janssen PA (1984) Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentanyl from saline: characteristics of partial generalization. J Pharmacol Exp Ther 230:193\u2013199","journal-title":"J Pharmacol Exp Ther"},{"key":"4514_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2010.12.003","volume":"654","author":"CS Cunningham","year":"2011","unstructured":"Cunningham CS, McMahon LR (2011) The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in \u03b14\u03b22 nicotinic receptor activation. Eur J Pharmacol 654:47\u201352","journal-title":"Eur J Pharmacol"},{"key":"4514_CR8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00213-013-3037-5","volume":"228","author":"CS Cunningham","year":"2013","unstructured":"Cunningham CS, McMahon LR (2013) Multiple nicotine training doses in mice as a basis for differentiating the effects of smoking cessation aids. Psychopharmacology 228:321\u2013333","journal-title":"Psychopharmacology"},{"key":"4514_CR9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/FBP.0000000000000233","volume":"27","author":"FB Moura de","year":"2016","unstructured":"de Moura FB, McMahon LR (2016) Differential antagonism and tolerance\/cross-tolerance among nicotinic acetylcholine receptor agonists: scheduled-controlled responding and hypothermia in C57BL\/6J mice. Behav Pharmacol 27:240\u2013248","journal-title":"Behav Pharmacol"},{"key":"4514_CR10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1124\/jpet.110.173773","volume":"335","author":"RI Desai","year":"2010","unstructured":"Desai RI, Bergman J (2010) Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds. J Pharmacol Exp Ther 335:807\u2013816","journal-title":"J Pharmacol Exp Ther"},{"key":"4514_CR11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00008877-198900110-00004","volume":"1","author":"HS Garcha","year":"1989","unstructured":"Garcha HS, Stolerman IP (1989) Discrimination of a drug mixture in rats: role of training dose, and specificity. Behav Pharmacol 1:25\u201331","journal-title":"Behav Pharmacol"},{"key":"4514_CR12","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.neuropharm.2010.01.013","volume":"58","author":"SR Grady","year":"2010","unstructured":"Grady SR, Drenan RM, Breining SR, Yohannes D, Wageman CR, Fedorov NB, McKinney S, Whiteaker P, Bencherif M, Lester HA, Marks MJ (2010) Structural differences determine the relative selectivity of nicotinic compounds for native \u03b14\u03b22*-, \u03b16\u03b22*-, \u03b13\u03b24*- and \u03b17-nicotinic acetylcholine receptors. Neuropharmacology 58:1054\u20131066","journal-title":"Neuropharmacology"},{"key":"4514_CR13","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0091-3057(99)00075-1","volume":"64","author":"K Grant","year":"1999","unstructured":"Grant K (1999) Strategies for understanding the pharmacological effects of ethanol with drug discrimination procedures. Pharmacol Biochem Behav 64:261\u2013267","journal-title":"Pharmacol Biochem Behav"},{"key":"4514_CR14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0376-8716(98)00086-6","volume":"52","author":"KL Green","year":"1998","unstructured":"Green KL, Grant KA (1998) Evidence for overshadowing by components of the heterogeneous discriminative stimulus effects of ethanol. Drug Alcohol Depend 52:149\u2013159","journal-title":"Drug Alcohol Depend"},{"key":"4514_CR15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1124\/jpet.104.076968","volume":"312","author":"M Haj\u00f3s","year":"2005","unstructured":"Haj\u00f3s M, Hurst RS, Hoffman WE, Krause K, Wall TM, Higdon NR, Groppi VE (2005) The selective \u03b17 nicotinic acetylcholine receptor agonist PNU-282978 [N-[(3R)-1-azabicyclo[2.2.2]octy-3-yl]-4-chlorobenzamine hydrochloride] enhances GABAergic synaptic activity in brain slices and restores auditory gating deficits in anesthetized rats. J Pharmacol Exp Ther 312:1213\u20131222","journal-title":"J Pharmacol Exp Ther"},{"key":"4514_CR16","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.amjmed.2008.01.017","volume":"121","author":"JT Hays","year":"2008","unstructured":"Hays JT, Ebbert JO, Sood A (2008) Efficacy and safety of varenicline for smoking cessation. Am J Med 121:S32\u2013S42","journal-title":"Am J Med"},{"key":"4514_CR17","volume-title":"Guide for the care and use of laboratory animals 8th ed. Institute for Laboratory Animal Research","author":"Institute for Laboratory Animal Research","year":"2011","unstructured":"Institute for Laboratory Animal Research (2011) Guide for the care and use of laboratory animals 8th ed. Institute for Laboratory Animal Research. Division of Earth and Life Sciences, National Research Council, Washington"},{"key":"4514_CR18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1124\/jpet.111.182170","volume":"339","author":"EM Jutkiewicz","year":"2011","unstructured":"Jutkiewicz EM, Brooks EA, Kynaston AD, Rice KC, Woods JH (2011) Patterns of nicotinic receptor antagonism: nicotine discrimination studies. J Pharmacol Exp Ther 339:194\u2013202","journal-title":"J Pharmacol Exp Ther"},{"key":"4514_CR19","volume-title":"Pharmacologic analysis of drug-receptor interaction","author":"TP Kenakin","year":"1997","unstructured":"Kenakin TP (1997) Pharmacologic analysis of drug-receptor interaction. Lippincott-Raven, Philadelphia"},{"key":"4514_CR20","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1146\/annurev.pharmtox.42.091401.113012","volume":"42","author":"T Kenakin","year":"2002","unstructured":"Kenakin T (2002) Drug efficacy at G protein-coupled receptors. Annu Rev Pharmacol Toxicol 42:349\u2013379","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4514_CR21","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1021\/jm020562o","volume":"46","author":"ME Kuehne","year":"2003","unstructured":"Kuehne ME, He L, Jokiel PA, Pace CJ, Fleck MW, Maisonneuve IM, Glick SD, Bidlack JM (2003) Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents. J Med Chem 46:2716\u20132730","journal-title":"J Med Chem"},{"key":"4514_CR22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/jpet.111.185306","volume":"339","author":"SC Lummis","year":"2011","unstructured":"Lummis SC, Thompson AJ, Bencherif M, Lester HA (2011) Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor. J Phamacol Exp Ther 339:125\u2013131","journal-title":"J Phamacol Exp Ther"},{"key":"4514_CR23","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1124\/mol.106.025130","volume":"70","author":"KB Mihalak","year":"2006","unstructured":"Mihalak KB, Carroll FI, Luetje CW (2006) Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Mol Pharmacol 70:801\u2013805","journal-title":"Mol Pharmacol"},{"key":"4514_CR24","doi-asserted-by":"crossref","unstructured":"Moerke MJ, de Moura FB, Koek W, McMahon LR (2016) Effects of nicotine in combination with drugs described as positive allosteric nicotinic acetylcholine receptor modulators in vitro: discriminative stimulus and hypothermic effects in mice. Eur J Pharmacol 786:169\u2013178","DOI":"10.1016\/j.ejphar.2016.05.032"},{"key":"4514_CR25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.neuropharm.2008.03.010","volume":"54","author":"RL Papke","year":"2008","unstructured":"Papke RL, Dwoskin LP, Crooks PA, Zheng G, Zhang Z, McIntosh JM, Stokes C (2008) Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras. Neuropharmacology 54:1189\u20131200","journal-title":"Neuropharmacology"},{"key":"4514_CR26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/34413","volume":"391","author":"MR Picciotto","year":"1998","unstructured":"Picciotto MR, Zoli M, Rimondini R, L\u00e9na C, Marubio LM, Pich EM, Fuxe K, Changeux JP (1998) Acetylcholine receptors containing the \u03b22 subunit are involved in the reinforcing properties of nicotine. Nature 391:173\u2013177","journal-title":"Nature"},{"key":"4514_CR27","doi-asserted-by":"crossref","unstructured":"Rodriguez JS, Cunningham CS, Moura FB, Ondachi P, Carroll FI, McMahon LR (2014) Discriminative stimulus and hypothermic effects of some derivatives of the nAChR agonist epibatidine in mice. Psychopharmacology (Berl) 231:4455\u20134466","DOI":"10.1007\/s00213-014-3589-z"},{"key":"4514_CR28","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.neuropharm.2006.10.016","volume":"52","author":"H Rollema","year":"2007","unstructured":"Rollema H, Chambers LK, Coe JW, Glowa J, Hurst RS, Lebel LA, Lu Y, Mansbach RS, Mather RJ, Rovetti CC, Sands SB, Schaeffer E, Schulz DW, Tingley FD III, Williams KE (2007a) Pharmacological profile of the \u03b14\u03b22 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. Neuropharmacology 52:985\u2013994","journal-title":"Neuropharmacology"},{"key":"4514_CR29","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.tips.2007.05.003","volume":"28","author":"H Rollema","year":"2007","unstructured":"Rollema H, Coe JW, Chambers LK, Hurst RS, Stahl SM, Williams KE (2007b) Rationale, pharmacology and clinical efficacy of partial agonists of \u03b14\u03b22 nACh receptors for smoking cessation. Trends Pharmacol Sci 28:316\u2013325","journal-title":"Trends Pharmacol Sci"},{"key":"4514_CR30","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0028-3908(01)00194-0","volume":"42","author":"M Shoaib","year":"2002","unstructured":"Shoaib M, Gommans J, Morley A, Stolerman IP, Grailhe R, Changeux JP (2002) The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology 42:530\u2013539","journal-title":"Neuropharmacology"},{"key":"4514_CR31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-006-0596-8","volume":"190","author":"JW Smith","year":"2007","unstructured":"Smith JW, Mogg A, Tafi E, Peacey E, Pullar IA, Szekeres P, Tricklebank M (2007) Ligands selective for \u03b14\u03b22 but not \u03b13\u03b24 or \u03b17 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat. Psychopharmacology 190:157\u2013170","journal-title":"Psychopharmacology"},{"key":"4514_CR32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s002130050205","volume":"129","author":"IP Stolerman","year":"1997","unstructured":"Stolerman IP, Chandler CJ, Garcha HS, Newton JM (1997) Selective antagonism of behavioural effects of nicotine by dihydro-\u03b2-erythroidine in rats. Psychopharmacology 129:390\u2013397","journal-title":"Psychopharmacology"},{"key":"4514_CR33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s002130050837","volume":"141","author":"IP Stolerman","year":"1999","unstructured":"Stolerman IP, Naylor C, Elmer GI, Goldberg SR (1999) Discrimination and self-administration of nicotine by inbred strains of mice. Psychopharmacology 141:297\u2013306","journal-title":"Psychopharmacology"},{"key":"4514_CR34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.neuropharm.2003.10.002","volume":"46","author":"IP Stolerman","year":"2004","unstructured":"Stolerman IP, Chamberlain S, Bizarro L, Fernandes C, Schalkwyk L (2004) The role of nicotinic receptor \u03b17 subunits in nicotine discrimination. Neuropharmacology 46:363\u2013371","journal-title":"Neuropharmacology"},{"key":"4514_CR35","doi-asserted-by":"crossref","DOI":"10.1201\/9781420036107","volume-title":"Drug synergism and dose-effect data analysis","author":"RJ Tallarida","year":"2000","unstructured":"Tallarida RJ (2000) Drug synergism and dose-effect data analysis. Chapman Hall\/CRC Press, Boca Raton"},{"key":"4514_CR36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0014-5793(90)81231-C","volume":"270","author":"JM Ward","year":"1990","unstructured":"Ward JM, Cockcroft VB, Lunt GG, Smillie FS, Wonnacott S (1990) Methyllycaconitine: a selective probe for neuronal alpha-bungarotoxin binding sites. FEBS Lett 270:45\u201348","journal-title":"FEBS Lett"},{"key":"4514_CR37","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/00008877-199406000-00013","volume":"5","author":"JA White","year":"1994","unstructured":"White JA, Stolerman IP (1994) Antagonism of a nicotine plus midazolam discriminative cue in rats. Behav Pharmacol 5:351\u2013355","journal-title":"Behav Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4514-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-016-4514-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4514-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T22:33:55Z","timestamp":1749854035000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-016-4514-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,27]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["4514"],"URL":"https:\/\/doi.org\/10.1007\/s00213-016-4514-4","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,27]]}}}